lobbying_activities: 1697754

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1697754	75507192-c6ba-42f1-8245-cb00237509f0	Q2	EMPIRE CONSULTING GROUP	400703105	PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA	2015	second_quarter	PHA	Medicare Prescription Drug Act; HR 9, Innovation Act; HR 2005/S. 1083, Medicare Drug Savings Act; 340B Drug pricing program; 21st Century Cures; S.320, Medical Innovation Act; and Independent Payment Advisory Board (IPAB) repeal.	HOUSE OF REPRESENTATIVES	40000		0	0	2015-07-15T19:46:18.450000-04:00